We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Claims In Securities Class Action Against Drug Maker Found To Be Insufficient

Mealey's (April 3, 2018, 2:04 PM EDT) -- NEW YORK — Although lead plaintiffs in a securities class action against a drug company and its co-founders have shown that the defendants acted with the requisite scienter, they have failed...
To view the full article, register now.